Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 20, 2014 08:30 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Welcomes Presentation of Clinical Data on Galectin-3 Testing at the American Heart Association 2014 Scientific Sessions Conference

WALTHAM, Mass., Nov. 20, 2014 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, announced today that 17 abstracts reporting independent research that...
November 13, 2014 06:30 ET | Source: BG Medicine, Inc.

BG Medicine Reports Third Quarter 2014 Financial Results

Net Loss Reduced by 35% and Operating Cash Burn Cut by 48% From Third Quarter 2013 Company Retains Investment Bank to Explore Strategic Alternatives WALTHAM, Mass., Nov. 13, 2014 (GLOBE...
November 07, 2014 10:45 ET | Source: BG Medicine, Inc.

BG Medicine Announces Q3 2014 Financial Results Release Date and Conference Call Information

WALTHAM, Mass., Nov. 7, 2014 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Thursday, November 13, 2014 at 8:30 a.m....
August 14, 2014 08:00 ET | Source: BG Medicine, Inc.

BG Medicine Reports Second Quarter 2014 Financial Results

WALTHAM, Mass., Aug. 14, 2014 (GLOBE NEWSWIRE) -- BGMedicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3®Test, today reported financial results for the second quarter 2014. Second...
August 07, 2014 20:00 ET | Source: BG Medicine, Inc.

BG Medicine Announces Q2 2014 Financial Results Release Date and Conference Call Information

WALTHAM, Mass., Aug. 7, 2014 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Thursday, August 14, 2014 at 8:30 a.m....
May 14, 2014 07:30 ET | Source: BG Medicine, Inc.

BG Medicine Reports First Quarter 2014 Financial Results

Net Loss Reduced by 60% and Operating Cash Burn Cut by 44% From First Quarter 2013 Continued Progress Made Toward Delivering on Critical Catalysts for Growth WALTHAM, Mass., May 14, 2014 (GLOBE...
May 07, 2014 16:30 ET | Source: BG Medicine, Inc.

BG Medicine Announces Q1 2014 Financial Results Release Date and Conference Call Information

WALTHAM, Mass., May 7, 2014 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Wednesday, May 14, 2014 at 8:30 a.m. Eastern...
April 03, 2014 09:15 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Prices $10.0 Million Public Offering of Common Stock

WALTHAM, Mass., April 3, 2014 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, today announced the pricing of the sale of 6,452,000 shares of its...
April 02, 2014 16:05 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Announces Proposed Public Offering of Common Stock

WALTHAM, Mass., April 2, 2014 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, today announced that it intends to offer and sell shares of its...
March 25, 2014 08:30 ET | Source: BG Medicine, Inc.

Publication Reports Clinical Utility of BGM Galectin-3(R) Test for Prediction of Near-Term Rehospitalization in Patients With Heart Failure

WALTHAM, Mass., March 25, 2014 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) announced today the publication of results, in the American Heart Journal, of an analysis of aggregated data from...